Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1

Abstract

Cleavage of amyloid precursor protein (APP) by the β- and γ-secretases generates the amino and carboxy termini, respectively, of the Aβ amyloidogenic peptides Aβ40 and Aβ42—the major constituents of the amyloid plaques in the brain parenchyma of Alzheimer's disease patients1. There is evidence that the polytopic membrane-spanning proteins, presenilin 1 and 2 (PS1 and PS2), are important determinants of γ-secretase activity: mutations in PS1 and PS2 that are associated with early-onset familial Alzheimer's disease2,3 increase the production of Aβ42 (refs 4,5,6), the more amyloidogenic peptide; γ-secretase activity is reduced in neuronal cultures derived from PS1-deficient mouse embryos7; and directed mutagenesis of two conserved aspartates in transmembrane segments of PS1 inactivates the ability of γ-secretase to catalyse processing of APP within its transmembrane domain8. It is unknown, however, whether PS1 (which has little or no homology to any known aspartyl protease) is itself a transmembrane aspartyl protease or a γ-secretase cofactor, or helps to colocalize γ-secretase and APP. Here we report photoaffinity labelling of PS1 (and PS2) by potent γ-secretase inhibitors that were designed to function as transition state analogue inhibitors directed to the active site of an aspartyl protease. This observation indicates that PS1 (and PS2) may contain the active site of γ-secretase. Interestingly, the intact, single-chain form of wild-type PS1 is not labelled by an active-site-directed photoaffinity probe, suggesting that intact wild-type PS1 may be an aspartyl protease zymogen.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Chemical structures of the γ-secretase inhibitor, L-685,458 and its derivatives: L-682,679 (hydroxy group epimer), L-405,484 (peptidic analogue), L-852,505 and L-852,646 (both photoreactive/biotinylated analogues).
Figure 2: Inhibitory potencies of L-685,458 and its derivatives in the in vitro γ-secretase assay.
Figure 3: Covalent labelling of PS1 by photoreactive active site directed γ-secretase inhibitors.
Figure 4: Photoactivated γ-secretase inhibitor does not bind covalently to intact wild-type PS1 but reacts with the PS1-FAD (‘familial Alzheimer's disease’) Δexon 9 mutant.

Similar content being viewed by others

References

  1. Selkoe, D. J. The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease. Trends Cell Biol. 8, 447– 453 (1998).

    Article  CAS  Google Scholar 

  2. Sherrington, R. et al. Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature 375, 754–760 (1995).

    Article  ADS  CAS  Google Scholar 

  3. Levy-Lahad, E. et al. A familial Alzheimer's disease locus on chromosome 1. Science 269, 970–973 ( 1995).

    Article  ADS  CAS  Google Scholar 

  4. Scheuner, D. et al. Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nature Med. 2, 864–870 ( 1996).

    Article  CAS  Google Scholar 

  5. Duff, K. et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710– 713 (1996).

    Article  ADS  CAS  Google Scholar 

  6. Borchelt, D. R. et al. Familial Alzheimer's disease-linked presenilin 1 variants elevate Abetal-42,1-40 ratio in vitro and in vivo. Neuron 17, 1005–1013 (1996).

    Article  CAS  Google Scholar 

  7. De Strooper, B. et al. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature 391, 387 –390 (1998).

    Article  ADS  CAS  Google Scholar 

  8. Wolfe, M. S. et al. Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513–517 ( 1999).

    Article  ADS  CAS  Google Scholar 

  9. Shearman, M. S. et al. L-685,458, an aspartic protease transition state mimic, is a potent inhibitor of APP γ-secretase activity. Biochemistry , in the press.

  10. Wolfenden, R. Analog approaches to the structure of the transition state in enzyme reactions. Accts. Chem. Res. 5, 10– 18 (1972).

    Article  CAS  Google Scholar 

  11. Rich, D. H. Inhibitors of Aspartic Proteinases. (eds. Barrett, A. J. & Salvesen, G.) 179–217 (Elsevier Science, 1986).

    Google Scholar 

  12. Li, Y.-M. et al. Presenilin-1 is linked with γ-secretase activity in the detergent solubilized state. Proc. Natl Acad. Sci. USA (in the press).

  13. Wolfe, M. S. et al. Peptidomimetic probes and molecular modeling suggest that Alzheimer's γ-secretase is an intramembrane-cleaving aspartyl protease. Biochemistry 38, 4720– 4727 (1999).

    Article  CAS  Google Scholar 

  14. Thinakaran, G. et al. Endoproteolysis of presenilin-1 and accumulation of processed derivatives in vivo. Neuron 17, 181– 190 (1996).

    Article  CAS  Google Scholar 

  15. Seeger, M. et al. Evidence for phosphorylation of oligomeric assembly of presenilin 1. Proc. Natl Acad. Sci. USA 94, 5090– 5094 (1997).

    Article  ADS  CAS  Google Scholar 

  16. Capell, A. et al. The proteolytic fragments of the Alzheimer's disease-associated presenilin-1 form heterodimers and occur as a 100–150-kDa molecular mass complex. J. Biol. Chem. 273, 3205– 3211 (1998).

    Article  CAS  Google Scholar 

  17. Perez-Tur, J. et al. A mutation in Alzheimer's disease destroying a splice acceptor site in the presenilin-1 gene. Neuroreport 7, 297–301 (1995).

    Article  CAS  Google Scholar 

  18. Thinakaran, G. et al. Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors. J. Biol. Chem. 272, 28415–28422 ( 1997).

    Article  CAS  Google Scholar 

  19. Evans, B. E. et al. A stereocontrolled synthesis of hydroxyethylene dipeptide isosteres using novel, chiral aminoalkyl epoxides and γ-(aminoalkyl) γ-lactones. J. Org. Chem. 50, 4615– 4625 (1985).

    Article  CAS  Google Scholar 

  20. Yang, H., Leland, J. K., Yost, D. & Massey, R. J. Electrochemiluminescence: A new diagnostic and research tool. Bio/Technology 12, 193–194 (1994).

    CAS  PubMed  Google Scholar 

  21. Khorkova, O. E., Patel, K., Heroux, J. & Sahasrabudhe, S. Modulation of amyloid precursor protein processing by compounds with various mechanisms of action: detection by liquid phase electrochemiluminescent system. J. Neurosci. Methods 82, 159–166 (1998).

    Article  CAS  Google Scholar 

  22. Ida, N. et al. Analysis of heterogeneous βA4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive western blot analysis. J. Biol. Chem. 271, 22908–22914 (1996).

    Article  CAS  Google Scholar 

  23. Barelli, H. L. et al. Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β-peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases. Mol. Med. 3, 695–707 (1997).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen J. Gardell.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, YM., Xu, M., Lai, MT. et al. Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1. Nature 405, 689–694 (2000). https://doi.org/10.1038/35015085

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/35015085

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing